MREO - Mereo BioPharma Group plc
2.39
0.060 2.510%
Share volume: 1,189,794
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.33
0.06
0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-12-2024 | 05-15-2024 | 08-13-2024 | 11-12-2024 | 03-26-2025 | |
| Total revenue | 0.000 | 9.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 3.430 M | -235.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 5.570 M | 235.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| inf% | -95.78% | -100.00% | nan% | nan% | nan% | |||
| Operating expenses | 11.757 M | 6.381 M | 9.302 M | 9.900 M | 12.814 M | 9.373 M | 15.277 M | |
| Selling general and admin | 6.450 M | 2.669 M | 5.708 M | 5.906 M | 7.868 M | 6.203 M | 6.457 M | |
| Research and development | 5.307 M | 3.712 M | 3.594 M | 3.994 M | 4.946 M | 3.170 M | 8.820 M | |
| Total expenses | 12.104 M | 6.381 M | 9.302 M | 9.900 M | 12.814 M | 9.373 M | 15.277 M | |
| -47.28% | 45.78% | 6.43% | 29.43% | -26.85% | 62.99% | |||
| Operating income | -11.410 M | -811.000 K | -9.067 M | -9.900 M | -12.814 M | -9.373 M | -15.277 M | |
| Ebit | -10.874 M | -1.095 M | -6.520 M | -9.258 M | -12.483 M | -15.631 M | -7.552 M | |
| Pretax income | -12.076 M | -1.751 M | -6.531 M | -8.951 M | -12.255 M | -15.001 M | -7.046 M | |
| -85.50% | 272.99% | 37.05% | 36.91% | 22.41% | -53.03% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -12.076 M | -1.751 M | -6.531 M | -8.951 M | -12.255 M | -15.001 M | -7.046 M | |
| 85.50% | -272.99% | -37.05% | -36.91% | -22.41% | 53.03% |
